Ludwig Researchers Present New Findings on Combination Immunotherapy and Other Research at the 2017 ASCO Annual Meeting
Ludwig Cancer Research released today the full scope of Ludwig’s participation at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, June 2-6.
31-May-2017 9:00 AM EDT Add to Favorites
The loss of the tumor suppressor gene PTEN has been linked to tumor growth and chemotherapy resistance in the almost invariably lethal brain cancer glioblastoma multiforme (GBM). Now, Ludwig researchers have shown that one way to override the...
12-May-2017 9:00 AM EDT Add to Favorites
Ludwig Scientists Reveal New Advances in Immunotherapy, Biomarkers and Treatment Resistance at 2017 AACR Annual Meeting
Ludwig Cancer Research released today the full scope of advances to be presented by Ludwig researchers at this year’s American Association for Cancer Research (AACR) Annual Meeting in Washington D.C., April 1-5, 2017.
29-Mar-2017 3:30 PM EDT Add to Favorites
Ludwig researchers have shown that triple-negative breast cancer cells ramp up production of a key component of DNA in response to chemotherapy and that targeting this pathway could undermine their resistance to such therapies.
2-Mar-2017 8:00 AM EST Add to Favorites
Ludwig researchers discover that circular DNA, once thought to be rare in tumor cells, is actually very common and seems to play a fundamental role in tumor evolution
8-Feb-2017 1:05 PM EST Add to Favorites
Findings uncover an ancient mechanism that makes cancer cells invasive, explains melanoma’s resistance to therapy and opens the door to development of novel cancer therapies
16-Jan-2017 5:00 PM EST Add to Favorites
It is with great pleasure that the Ludwig Institute for Cancer Research announces the appointment of Chi Van Dang as its Scientific Director.
20-Dec-2016 12:00 PM EST Add to Favorites
The Ludwig Institute for Cancer Research extends a warm welcome to Barbara S. Jones, the newest member of our Board of Directors.
7-Dec-2016 9:00 AM EST Add to Favorites